5-{[4-(trifluoromethyl)phenyl]methyl}-1,3,4-thiadiazol-2-amine

Catalog No. :
ACNEPC635
CAS No. :
1052694-85-5
Molecular Formula :
C10H8F3N3S
Molecular Weight :
259.26

IUPAC Name:5-(4-(trifluoromethyl)benzyl)-1,3,4-thiadiazol-2-amine

5-{[4-(trifluoromethyl)phenyl]methyl}-1,3,4-thiadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$81.00Login to see priceInquiryInquiry
1g95%$294.00Login to see priceInquiryInquiry
5g95%$845.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-{[4-(trifluoromethyl)phenyl]methyl}-1,3,4-thiadiazol-2-amine
IUPAC Name5-(4-(trifluoromethyl)benzyl)-1,3,4-thiadiazol-2-amine
MDL No.MFCD17031240
Molecular FormulaC10H8F3N3S
Molecular Weight259.26
SMILESNC1=NN=C(CC2=CC=C(C(F)(F)F)C=C2)S1
InChI KeyDNKNUHGUGHSKKO-UHFFFAOYSA-N
Synonym5-(4-(Trifluoromethyl)benzyl)-1,3,4-thiadiazol-2-amine;1,3,4-Thiadiazol-2-amine, 5-[[4-(trifluoromethyl)phenyl]methyl]-;2-Amino-5-[4-(trifluoromethyl)benzyl]-1,3,4-thiadiazole;5-{[4-(Trifluoromethyl)phenyl]methyl}-1,3,4-thiadiazol-2-amine
CAS No.1052694-85-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNEPC635 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNEPC635 route product structure diagram
    ACNEPC6351052694-85-5
Inquiry

2. ACNEPC635 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEPC635 route product structure diagram
    ACNEPC6351052694-85-5
Inquiry

Comments (0)